Pentagon Awards Glaxo $342m Contract For COVID Vaccines

Pentagon Awards Glaxo $342m Contract For COVID Vaccines
In this file photo taken on July 29, 2013, the headquarters of the British pharmaceutical company GlaxoSmithKline (GSK) is pictured in west London. Ben STANSALL / AFP
WhatsApp
Facebook
Twitter
Telegram
LinkedIn
Print

The Pentagon on Thursday announced a $342 million contract has been awarded to British pharmaceutical giant GlaxoSmithKline to deliver “mass quantities of COVID-19 vaccines” to US troops.

It said GSK was the only company to make a bid for the contract, which will consist of supporting “military locations and personnel throughout the continental US and outside the continental US.”

Read Also: COVID-19 Vaccine: Roche Drug Trial For COVID-19 Fails

The work will be carried out in North Carolina “with an estimated completion date of Feb. 28, 2021,” the Pentagon said.

The US Army will supervise execution of the project.

AFP

WhatsApp
Facebook
Twitter
Telegram
LinkedIn
Print